Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Obovatol induces apoptosis in breast cancer by downregulating the PI3K/Akt pathway
Ling Zhang1,2, Changyou Wei3, Xin Yang1,2
1College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background:
Obovatol (Ob), extracted from the bark of Magnolia obovata Thunb., originates from a genus with a well-documented history in East Asian traditional medicine for treating ailments characterized by inflammation and neoplastic-like symptoms. Despite preliminary observations suggesting that Ob exerts anti-tumor effects in various cancers, its specific efficacy and underlying mechanisms of action in breast cancer (BC) remain largely unexplored. This study aimed to investigate the anti-tumor efficacy of Ob against BC and to elucidate its underlying molecular mechanisms.
Methods:
Cell counting kit-8, Transwell, flow cytometry, and Western blotting (WB) assays were used to examine the effects and functions of Ob on cellular proliferation, invasion, and apoptosis in BC cells (MDA-MB-231 and MDA-MB-468). Bagg Albino/c (BALB/c) nude female mice were applied to evaluate the anti-cancer effects and biosecurity of Ob. Transcriptome sequencing was used to identify the pathway modulated by Ob in BC, and WB assays were then used to validate the key findings.
Results:
In MDA-MB-231 and MDA-MB-468 cells, Ob decreased the cell viability, exhibiting the half maximal inhibitory concentration (IC50) values for 50.97 and 48.29 µM, respectively. Additionally, by upregulating E-cadherin while downregulating N-cadherin and vimentin, Ob reversed the epithelial-mesenchymal transition, thereby significantly inhibiting the migration and invasion of BC cells. Ob led to mitochondrial apoptosis, as shown by reduced B-cell lymphoma 2 (Bcl-2) levels and elevated Bcl-2-associated X protein (Bax) and activated caspase-3 levels. Consistent with the in vitro findings, Ob treatment effectively limited tumor growth in the mouse model, demonstrating considerable biological safety. Importantly, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway has been proven to be a key mechanistic target, as Ob suppressed its activation.
Conclusions:
By downregulating the PI3K/Akt pathway, Ob reduced cell proliferation and invasion and induced apoptosis in BC.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...